Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for INVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2000. Start Trial.
Date Value
December 31, 2025 566.67M
December 31, 2024 412.50M
December 31, 2023 193.51M
December 31, 2022 291.05M
December 31, 2021 201.52M
December 31, 2020 246.49M
December 31, 2019 350.84M
December 31, 2018 114.91M
December 31, 2017 129.08M
December 31, 2016 150.43M
December 31, 2015 187.28M
December 31, 2014 240.50M
December 31, 2013 465.12M
Date Value
December 31, 2012 248.49M
December 31, 2011 240.92M
December 31, 2010 309.63M
December 31, 2009 155.39M
December 31, 2008 200.60M
December 31, 2007 126.82M
December 31, 2006 201.08M
December 31, 2005 161.92M
December 31, 2004 257.14M
December 31, 2003 243.54M
December 31, 2002 148.55M
December 31, 2001 152.98M
December 31, 2000 204.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Zevra Therapeutics, Inc. 191.01M
Collegium Pharmaceutical, Inc. 406.53M
CorMedix, Inc. 149.19M
ANI Pharmaceuticals, Inc. 294.75M
Corcept Therapeutics, Inc. 372.15M